Citation, DOI, disclosures and article data
Citation:
Weerakkody Y, Silverstone L, Knipe H, et al. Trastuzumab deruxtecan related interstitial lung disease. Reference article, Radiopaedia.org (Accessed on 12 Dec 2024) https://doi.org/10.53347/rID-180845
Trastuzumab deruxtecan related interstitial lung disease (T-Dxd ILD) is a form of drug induced lung disease which can rarely occur with the antibody-drug conjugate trastuzumab deruxtecan (T-DXd). It can cause a fatal pneumonitis and therefore its recognition is important.
Radiographic features
CT
Several patterns of lung injury have been described which include 2:
-
1. Jang Y, Jeong J, Kim J, Ahn J, Jung K, Kim S. CT Findings From Interstitial Lung Diseases in Patients With Metastatic Breast Cancer Treated With Fam-Trastuzumab Deruxtecan: A Single Institutional Experience. J Breast Cancer. 2022;25(1):49-56. doi:10.4048/jbc.2022.25.e1 - Pubmed
-
2. Nishino M, Kusumoto M, Bankier A et al. Trastuzumab Deruxtecan‒Related Interstitial Lung Disease/Pneumonitis: Computed Tomography Imaging Patterns to Guide Diagnosis and Management. JCO Precis Oncol. 2023;7(7):e2300391. doi:10.1200/PO.23.00391 - Pubmed
-
3. Abuhelwa Z, Alloghbi A, Alqahtani A, Nagasaka M. Trastuzumab Deruxtecan-Induced Interstitial Lung Disease/Pneumonitis in ERBB2-Positive Advanced Solid Malignancies: A Systematic Review. Drugs. 2022;82(9):979-87. doi:10.1007/s40265-022-01736-w - Pubmed
-
4. Powell C, Modi S, Iwata H et al. Pooled Analysis of Drug-Related Interstitial Lung Disease And/Or Pneumonitis in Nine Trastuzumab Deruxtecan Monotherapy Studies. ESMO Open. 2022;7(4):100554. doi:10.1016/j.esmoop.2022.100554 - Pubmed
-
5. Errisuriz K, Bazan D, Verduzco Jr. R, Guedez R. Trastuzumab-Induced Interstitial Pneumonitis. Cureus. 2023;15(7):e42116. doi:10.7759/cureus.42116 - Pubmed
Promoted articles (advertising)
Unable to process the form. Check for errors and try again.